You are here:

rimonabant 20mg tablet (Acomplia) In Oct 2008 the EMEA recommended temporary suspension of this product. The SMC advice has been withdrawn from the website

Advice has been withdrawn from the Website

Rimonabant 20mg tablet (Acomplia), for the treatment of obesity.

In October 2008 the EMEA recommended the temporary suspension of this product.

The SMC Advice has been removed from the website

Drug Details

Drug Name: rimonabant 20mg tablet (Acomplia) In Oct 2008 the EMEA recommended temporary suspension of this product. The SMC advice has been withdrawn from the website
SMC Drug ID: 341/07
Manufacturer: Sanofi-Aventis
Indication: Obesity
BNF Category:
Sub Category: 4.5 Drugs used in the treatment of obesity
Submission Type: Full submission
Status: Advice has been withdrawn from the Website
Date Advice Published: 12 February 2007

Extra Notes

On 23 October 2008 the EMEA recommended the temporary suspension of the marketing authorisaion of Acomplia (rimonabant) for overweight and obese patients.

Back